Raymond Syndrome

Raymond Syndrome is a rare stroke syndrome that happens when a small area in the front-middle part of the pons (a section of the brainstem) is damaged—most often by a tiny blood-vessel blockage (ischemic stroke). The hallmark pattern is “crossed” findings: the eye on the same side as the brain injury cannot move outward (abducens/6th nerve palsy), and the arm and leg on the opposite side of the body are weak or paralyzed. Some people also show weakness of the lower face on the side opposite the brain lesion (central facial palsy). Doctors describe two forms: classic Raymond syndrome (involves the abducens nerve plus the corticospinal and corticofacial tracts) and common Raymond syndrome (similar, but the facial pathway is spared). The lesion is usually in the ventral medial mid-pons and is very uncommon. EyeWikiRadiopaediaNCBI

Raymond syndrome is a brainstem localization syndrome that happens when there is damage in the front-middle part of the lower pons (the ventral medial caudal pons). This damage typically affects the abducens nerve fibers (cranial nerve VI) that move the eye outward, and the corticospinal tract fibers that carry strength signals from the brain to the opposite side of the body. Because the nerve fibers cross in the brainstem, patients usually have eye movement problems on the same side as the lesion and weakness on the opposite side of the body. It is very rare and only a small number of cases are described in medical literature. EyeWikiRadiopaedia

In its classic description, Raymond syndrome can include three findings: (1) weakness of the abducens nerve on the lesion side (the eye cannot move outward properly), (2) contralateral body weakness (arm and leg), and sometimes (3) contralateral central facial weakness (the lower face on the opposite side looks weak) due to upper motor neuron involvement. Some authors debate whether facial involvement is always present; case reports document the “classic” triad with contralateral facial paresis. PMCPubMed

Doctors recognize Raymond syndrome among the family of “crossed brainstem syndromes,” which help localize where a stroke or other lesion sits in the brainstem. Knowing these patterns also helps tell it apart from similar pontine syndromes like Millard-Gubler and Foville, which involve nearby structures and add facial nerve or gaze palsy features. PubMedEyeWikiRadiopaedia

---

Types

1) “Pure” Raymond syndrome.
This pattern shows abducens palsy on the same side as the lesion plus weakness on the opposite side of the body, without clear facial nerve (VII) nucleus involvement. This happens when the lesion hits the abducens fascicle and corticospinal tract but spares facial nerve fibers. Radiopaedia

2) “Classic” Raymond syndrome (with contralateral facial paresis).
In some patients, the lesion also injures fibers controlling the lower face on the opposite side, so there is contralateral central facial weakness along with the abducens palsy and opposite-side body weakness. This variant has been documented in case reports and is why descriptions sometimes include facial findings. PMCPubMed

---

Causes

Each cause is written simply and explains “how” it can injure the ventral medial pons.

1. Small-vessel (lacunar) pontine infarct. Tiny arteries that penetrate the pons can clog from long-standing high blood pressure or diabetes, cutting off blood to the abducens fibers and corticospinal tract. EyeWiki

2. Branch atheromatous disease. A bigger plaque at the opening of a penetrating artery blocks blood flow to a wider strip of the ventral pons and creates a larger stroke in that region. NCBI

3. Basilar artery thrombosis or embolus. A clot in the main artery on the brainstem front can block small branches that feed the ventral pons and trigger the Raymond pattern. Radiopaedia

4. Pontine hemorrhage. A small bleed in the ventral pons can directly damage the abducens fascicle and corticospinal fibers. EyeWiki

5. Cavernous malformation bleed. A vascular tangle (cavernoma) near the pontomedullary junction can ooze or bleed and produce the same focal signs. EyeWiki

6. Lacunar infarct from chronic hypertension. Long-term high blood pressure causes lipohyalinosis of small vessels, which is a common reason for lacunes in the pons. EyeWiki

7. Atherosclerosis of vertebrobasilar system. Narrowing of these vessels reduces flow to the paramedian pontine branches and sets up small or medium infarcts. Radiopaedia

8. Cardioembolism. A clot from the heart can lodge in basilar branches and selectively injure the ventral medial pons. Radiopaedia

9. Multiple sclerosis (demyelination). An inflammatory plaque in the pons can disconnect the abducens fascicle and corticospinal tract and mimic the stroke pattern. Radiopaedia

10. Other inflammatory brainstem encephalitides. Conditions like Bickerstaff or autoimmune brainstem inflammation can inflame these pathways acutely. Radiopaedia

11. Primary brainstem tumor. A glioma in the lower pons can slowly infiltrate the ventral fibers and cause the same crossed signs. Radiopaedia

12. Metastatic tumor. A metastasis landing in the ventral pons can compress or destroy these tracts. Radiopaedia

13. Central pontine myelinolysis (osmotic demyelination). Rapid shifts in sodium can strip myelin in the pons and cause focal tract dysfunction. Radiopaedia

14. Traumatic brainstem injury. Shearing or contusion at the ventral pons can selectively damage these fibers. Radiopaedia

15. Iatrogenic injury. Rarely, brainstem surgery or catheter procedures can compromise small perforator branches and injure this area. Radiopaedia

16. Vasculitis (e.g., primary CNS vasculitis, lupus). Inflamed vessels narrow or clot and reduce blood flow to pontine branches. Radiopaedia

17. Infectious rhombencephalitis (e.g., Listeria, TB). Infection inflames or destroys focal brainstem tissue. Radiopaedia

18. Vertebrobasilar dolichoectasia (arterial enlargement). A stretched basilar artery can compress or distort brainstem structures or their blood supply. Radiopaedia

19. Venous thrombosis with congestion. Uncommon venous outflow problems can swell the pons and interrupt function. Radiopaedia

20. Congenital vascular malformations (non-cavernous). Developmental vessel anomalies can bleed or steal blood from the ventral pons. Radiopaedia

---

Symptoms

1. Double vision (horizontal). The patient sees two side-by-side images because the affected eye cannot move outward normally. PMC

2. Trouble moving the eye outward. The eye on the same side as the lesion fails to abduct due to abducens fascicle damage. Radiopaedia

3. Eye turning inward at rest (esotropia). Because the outward pull is weak, the inward muscle dominates and the eye points in. Radiopaedia

4. Weakness on the opposite side of the body. Arm and leg on the other side feel weak because corticospinal fibers are hit before they cross. Radiopaedia

5. Stiff, brisk reflexes on the weak side. This “upper motor neuron” pattern often accompanies the weakness. EMRO Dashboards

6. Clumsy walking or imbalance. Gait is unsteady because one side is weak and vision is doubled. PMC

7. Slurred speech (dysarthria). Weakness and brainstem involvement can make speech sound slurred. PMC

8. Face droop of the lower face on the opposite side (sometimes). In the “classic” form, the lower face on the other side looks weak due to central facial paresis. PMC

9. Mild numb feelings are uncommon. Sensation is often normal in “pure” Raymond because main sensory tracts are spared. EMRO Dashboards

10. Headache at onset (variable). Some patients feel a new head pain with stroke or hemorrhage. Radiopaedia

11. Dizziness or lightheadedness. The mismatch in eye signals and weakness can make balance feel off. Radiopaedia

12. Eye strain and fatigue. Trying to fuse double images is tiring. Radiopaedia

13. Reading difficulty. Tracking lines is hard when one eye cannot move outward well. Radiopaedia

14. Depth-perception problems. Stereo vision suffers when the eyes are misaligned. Radiopaedia

15. Sudden onset of the above (in vascular causes). Stroke produces symptoms that start quickly, often within minutes to hours. Radiopaedia

---

Diagnostic Tests

(Organized by category. The goal is to confirm the location in the pons, identify the cause, and rule out look-alikes like Foville or Millard-Gubler.)

A) Physical Examination

1. Full cranial nerve exam. The clinician checks eye movements and sees that the affected eye cannot move outward, while other movements may be preserved; this pattern points to abducens fascicle involvement in the pons. Radiopaedia

2. Motor strength and tone testing. The doctor grades strength and reflexes and often finds opposite-side weakness with brisk reflexes, helping localize to the corticospinal tract in the ventral pons. EMRO Dashboards

3. Facial movement testing. The clinician looks for central (lower) facial weakness on the side opposite the lesion in the “classic” type, which supports involvement of supranuclear facial pathways. PMC

4. Gait and coordination assessment. Simple walking and heel-to-toe tests show imbalance that can result from weakness and diplopia, supporting a brainstem localization. Radiopaedia

5. Vital signs and stroke screen. Blood pressure, pulse, and a rapid stroke assessment help identify acute vascular causes that fit the Raymond pattern. Radiopaedia

B) Manual / Bedside Neuro-ophthalmic Tests

6. Cover–uncover and alternate cover tests. These bedside tests show an inward eye drift and a weakness when the eye tries to move out, confirming a horizontal misalignment pattern. EyeWiki

7. Ocular versions and ductions charting. The examiner guides the eyes in all directions and documents limited abduction on the affected side, which matches abducens fascicle injury. EyeWiki

8. Hess or Lancaster red–green plotting (if available). These charts map the pattern of muscle under-action and over-action and help confirm a neurogenic abducens palsy rather than a mechanical eye muscle problem. EyeWiki

9. Saccade and pursuit testing. The clinician watches quick and smooth eye movements to confirm isolated lateral rectus weakness without a conjugate gaze palsy (which would suggest Foville instead). EyeWikiRadiopaedia

10. Diplopia field testing. Simple bedside mapping shows where double vision is worst (usually on looking toward the weak lateral rectus), supporting the lesion’s pathway. EyeWiki

C) Laboratory / Pathological Tests

11. Stroke risk panel (glucose/HbA1c, fasting lipids). These tests look for diabetes and cholesterol problems that cause small-vessel pontine strokes. Radiopaedia

12. Blood pressure monitoring and renal panel. Hypertension drives small-vessel disease, so measuring and managing it is essential. EyeWiki

13. Inflammatory/autoimmune screen (ESR/CRP, ANA, antiphospholipid, etc.). These tests look for vasculitis or clotting disorders that can injure pontine vessels. Radiopaedia

14. Infection work-up when indicated (e.g., cultures, TB tests, Lyme serology). Used when history suggests rhombencephalitis or other infection that targets the brainstem. Radiopaedia

15. Electrolytes and sodium for osmotic myelinolysis risk. Rapid sodium changes can demyelinate the pons and mimic these signs. Radiopaedia

D) Electrodiagnostic Tests

16. Brainstem Auditory Evoked Potentials (BAEPs). These measure electrical signals through the lower brainstem and can show delayed conduction consistent with pontine dysfunction when imaging is unclear. Radiopaedia

17. Oculographic movement recording (EOG or video-oculography). Objective recording of eye movements documents abduction failure and helps separate a fascicular abducens palsy from a conjugate gaze palsy (Foville). Radiopaedia

E) Imaging Tests

18. MRI brain with diffusion-weighted imaging (DWI). This is the key test to see an acute pontine infarct in the ventral medial pons and confirm the lesion that matches the exam. EMRO Dashboards

19. MRA/CTA of head and neck. Vessel imaging checks the basilar artery and its branches for narrowing, clots, or other problems that cut blood flow to the ventral pons. Radiopaedia

20. Susceptibility-weighted MRI (SWI) or non-contrast CT. These help detect hemorrhage or a cavernous malformation bleed that can produce the same focal signs. EyeWiki

Non-Pharmacological Treatments (Therapies & Others)

How to read this section: each item explains what it is, why it’s done (purpose), and how it helps (mechanism).

1. Acute stroke positioning and airway care
   Purpose: protect brain and lungs early after stroke.
   Mechanism: head-of-bed elevation and airway support improve oxygenation and reduce aspiration, limiting secondary brain injury.

2. Early mobilization with a physical therapist
   Purpose: regain strength, balance, and walking.
   Mechanism: graded, task-specific training drives neuroplasticity (the brain’s ability to rewire) and prevents complications like deconditioning and clots.

3. Task-oriented occupational therapy
   Purpose: restore independence in daily activities (dressing, bathing, cooking).
   Mechanism: repetitive, meaningful tasks re-train motor planning and fine motor control.

4. Speech and language therapy
   Purpose: improve speech clarity and communication if dysarthria is present.
   Mechanism: targeted exercises strengthen and coordinate mouth, tongue, and breathing muscles.

5. Swallow (dysphagia) therapy
   Purpose: reduce choking and pneumonia risk; maintain nutrition.
   Mechanism: compensatory techniques (e.g., chin-tuck, texture modification) and exercises improve safe swallowing pathways.

6. Neuro-ophthalmology care with occlusion (eye patch) for double vision
   Purpose: reduce troublesome double vision while nerves recover.
   Mechanism: temporarily blocks one image to prevent visual confusion.

7. Fresnel/prism lenses
   Purpose: fuse images to reduce diplopia during recovery.
   Mechanism: prismatic refraction redirects light so both eyes’ images align.

8. Balance and vestibular rehabilitation
   Purpose: decrease dizziness and falls.
   Mechanism: gaze stabilization and balance training recalibrate sensory inputs.

9. Constraint-induced movement therapy (when appropriate)
   Purpose: improve use of the weak arm/hand.
   Mechanism: temporarily limiting the stronger limb forces the brain to practice and strengthen the weaker limb’s pathways.

10. Functional electrical stimulation (FES)
    Purpose: assist weak muscles (e.g., ankle dorsiflexors) during walking.
    Mechanism: mild electrical pulses trigger muscle contraction at the right time, reinforcing correct motor patterns.

11. Robotic or body-weight-supported gait training
    Purpose: safely increase walking practice volume.
    Mechanism: repetitive stepping with partial support strengthens neural circuits for gait.

12. Home safety modifications
    Purpose: prevent falls and injury.
    Mechanism: grab bars, non-slip mats, and clear pathways reduce environmental risk.

13. Stroke education and caregiver training
    Purpose: improve adherence and recovery.
    Mechanism: understanding warning signs, medications, diet, and therapy increases engagement and lowers recurrence risk. AHA JournalsAmerican College of Cardiology

14. Lifestyle coaching (sleep, stress, smoking/alcohol cessation)
    Purpose: cut future stroke risk and improve energy.
    Mechanism: better sleep, stress control, and quitting tobacco/alcohol reduce blood pressure, inflammation, and vascular strain. AAFP

15. Aerobic exercise plan (after medical clearance)
    Purpose: enhance endurance and reduce vascular risk.
    Mechanism: moderate intensity exercise improves blood pressure, lipids, insulin sensitivity, and cerebral blood flow. AAFP

16. Eye movement exercises when safe
    Purpose: aid adaptation to eye misalignment.
    Mechanism: careful, clinician-guided drills encourage central compensation and fusion.

17. Psychological support and post-stroke depression screening
    Purpose: improve mood, motivation, and participation in rehab.
    Mechanism: counseling and behavioral strategies reduce depression/anxiety that often follow brainstem strokes.

18. Return-to-driving/work assessments
    Purpose: ensure safety and plan accommodations.
    Mechanism: standardized tests identify visual, motor, or cognitive gaps and direct training or workplace changes.

19. Community-based rehab programs and support groups
    Purpose: maintain gains and reduce isolation.
    Mechanism: ongoing peer and therapist support sustains practice and confidence.

20. Secondary prevention coaching (BP, diabetes, AFib, cholesterol)
    Purpose: stop another stroke.
    Mechanism: structured follow-up, home BP checks, and adherence support keep risk factors controlled long-term. AHA JournalsAmerican College of Cardiology

---

Drug Treatments

Important: Doses and timing depend on age, kidney/liver function, drug interactions, stroke type, and local protocols. These examples are for general education.

1. Alteplase (tPA), thrombolytic
   Dose/Time: 0.9 mg/kg IV (max 90 mg): 10% bolus, then 90% over 60 min; given within the eligible time window for acute ischemic stroke.
   Purpose: dissolve the clot early.
   Mechanism: activates plasminogen on fibrin to break down the clot.
   Side effects: bleeding (including brain), angioedema, hypotension. PMC

2. Tenecteplase (TNK), thrombolytic (alternative to alteplase in some settings)
   Dose/Time: 0.25 mg/kg IV bolus (max 25 mg) in eligible patients; often considered when thrombectomy is planned/possible.
   Purpose/Mechanism: single-bolus fibrin-specific thrombolysis; practical in transfer settings.
   Side effects: bleeding risks similar to alteplase. Canadian Stroke Best PracticesDrug Information GroupAHA Journals

3. Mechanical thrombectomy adjunct meds (periprocedural heparinization varies by center)
   Purpose: endovascular clot removal in basilar artery occlusion can improve outcomes in appropriate patients.
   Mechanism: stent-retriever/aspiration removes clot from basilar artery.
   Risks: bleeding, vessel injury, procedural complications. European Stroke OrganisationPMC

4. Aspirin, antiplatelet
   Dose: 160–325 mg daily initially, then 81–100 mg daily for long-term (if not receiving acute thrombolysis within the last 24 h or with clinician timing).
   Purpose: secondary prevention by preventing platelet aggregation.
   Mechanism: irreversible COX-1 inhibition.
   Side effects: gastric upset/bleeding.

5. Clopidogrel, antiplatelet
   Dose: 75 mg daily; sometimes a short course of dual therapy with aspirin in minor non-cardioembolic stroke/TIA.
   Purpose: lowers early recurrence risk.
   Mechanism: P2Y12 receptor blockade.
   Side effects: bleeding, rash. AHA Journals

6. Anticoagulation for cardioembolic sources (e.g., atrial fibrillation): Apixaban (DOAC)
   Dose: 5 mg twice daily (2.5 mg twice daily in select older/low-weight/renal-impaired patients).
   Purpose: prevent new clots from the heart.
   Mechanism: factor Xa inhibition.
   Side effects: bleeding; dosing and timing after stroke individualized. AHA Journals

7. Warfarin (vitamin K antagonist) for mechanical valves or when DOACs are unsuitable
   Dose: individualized to INR target (often 2.0–3.0).
   Purpose/Mechanism: reduces formation of cardioembolic clots.
   Side effects: bleeding; food/drug interactions require close monitoring. AHA Journals

8. High-intensity statins: Atorvastatin or Rosuvastatin
   Dose: Atorvastatin 80 mg nightly (or Rosuvastatin 20–40 mg).
   Purpose: reduce recurrent stroke and cardiovascular events.
   Mechanism: LDL lowering and plaque-stabilizing effects.
   Side effects: myalgias (rare rhabdomyolysis), mild liver enzyme rise. American College of CardiologyPMC

9. Blood-pressure control in the acute period: Nicardipine IV (example)
   Dose: 5 mg/h IV infusion, titrate up by 2.5 mg/h every 5–15 min (max about 15 mg/h) per protocol to target BP in eligible patients.
   Purpose: keep BP in the safe range for brain perfusion and to allow thrombolysis when indicated.
   Mechanism: calcium-channel vasodilation.
   Side effects: hypotension, headache. www.heart.org

10. Botulinum toxin type A (for persistent 6th-nerve palsy–related eye misalignment)
    Dose: tiny, clinician-determined intramuscular doses to the medial rectus (dosing and timing vary).
    Purpose: reduce inward pull of the medial rectus to lessen double vision while the lateral rectus recovers or before/after surgery.
    Mechanism: temporary acetylcholine blockade weakens the overacting muscle for several months.
    Side effects: transient ptosis, over- or under-correction, rare complications. AAOCochrane Library

---

Dietary “Molecular” Supplements

These do not treat Raymond Syndrome directly. They support overall vascular health and recovery when appropriate. Avoid interactions with your medicines.

1. Omega-3 EPA/DHA (fish oil) – about 1–2 g/day combined EPA+DHA.
   Function/Mechanism: anti-inflammatory lipid mediators; may modestly lower triglycerides and support vascular health.

2. Folic acid + Vitamins B6/B12 – e.g., folate 0.4–1 mg/day with B6/B12 as needed.
   Function: lowers homocysteine when elevated, which is linked to vascular risk in some people.

3. Vitamin D3 – dose per blood level (commonly 800–2000 IU/day, individualized).
   Function: supports immune and muscle function; deficiency is common.

4. Magnesium (e.g., 200–400 mg/day)
   Function: may aid blood pressure control and neuromuscular function; avoid if kidney disease.

5. Coenzyme Q10 (100–200 mg/day)
   Function: mitochondrial support; sometimes used to counter statin-associated muscle symptoms (discuss with your doctor).

6. Cocoa flavanols (e.g., high-flavanol cocoa)
   Function: endothelial nitric-oxide support → improved vascular function (food-first approach).

7. Green tea catechins
   Function: antioxidant polyphenols that may support vascular health.

8. Aged garlic extract (standardized allicin)
   Function: small BP and lipid benefits in some studies; avoid around surgery or with anticoagulants due to bleeding risk.

9. Probiotics (strain-specific)
   Function: gut-metabolism effects that may modestly help lipids and inflammation.

10. Fiber (psyllium or food-first)
    Function: improves cholesterol and glycemic control; target 25–30 g/day from diet first.
    (For overall secondary prevention, a Mediterranean-style eating pattern with sodium moderation is strongly recommended.) AAFP

---

Regenerative / Stem-Cell” Drugs — what’s real

There are no approved stem-cell drugs or “immunity boosters” proven to treat Raymond Syndrome. Experimental approaches are studied inside clinical trials only. It’s important—and safest—to avoid unproven therapies marketed online.

• Mesenchymal stem cells (MSCs), neural stem cells, or CD34+ cells: investigated in small studies for ischemic stroke recovery; dosing, route, and timing vary by protocol. Use only within regulated clinical trials.

• G-CSF, erythropoietin, citicoline, cerebrolysin, minocycline, N-acetylcysteine: researched as neuroprotective or regenerative aids with mixed results; none are standard of care for pontine stroke.
  Bottom line: do not self-start any “regenerative” product. If interested, ask your neurologist about legitimate clinical trials registered with recognized authorities. (No dosing provided here because appropriate dosing is protocol-specific and outside approved therapy.)

---

Procedures / Surgeries

1. Endovascular mechanical thrombectomy for basilar artery occlusion
   Why: in eligible patients with a blocked basilar artery causing the pontine stroke, physically removing the clot can improve outcomes when performed within appropriate time-windows.
   How: a catheter retrieves or aspirates the clot. European Stroke OrganisationPMC

2. Intravenous thrombolysis (tPA or TNK) as a time-critical procedure
   Why: dissolve the clot early to reduce brainstem damage.
   How: systemic clot-busting medicine given under strict eligibility and timing rules. PMCCanadian Stroke Best Practices

3. Decompressive posterior fossa surgery (rare, selected cases)
   Why: relieve dangerous pressure from swelling or large hemorrhage in the posterior fossa.
   How: removal of part of skull to create space; considered only in life-threatening scenarios.

4. Microsurgical resection or radiosurgery for a symptomatic cavernous malformation (select cases)
   Why: if a vascular malformation in the pons keeps bleeding, specialized centers may consider targeted therapy.
   How: meticulous brainstem surgery or focused radiation after strict risk–benefit review.

5. Strabismus surgery (e.g., medial rectus recession, lateral rectus resection, or vertical rectus transposition) for persistent 6th-nerve palsy
   Why: correct eye misalignment and reduce double vision when conservative options fail.
   How: re-balance the eye muscles; sometimes combined with botulinum injections. ScienceDirect

---

Preventions

1. Control blood pressure: aim for your clinician’s target; check at home.

2. Treat atrial fibrillation or cardiac sources of emboli: use the right anticoagulant when indicated.

3. High-intensity statin therapy: usually atorvastatin 80 mg unless not tolerated.

4. Antiplatelet therapy (for non-cardioembolic stroke): stick to the plan your doctor prescribes.

5. Stop smoking and avoid second-hand smoke.

6. Limit alcohol: none or within guideline limits.

7. Mediterranean-style eating pattern with sodium moderation.

8. Regular physical activity: build up to guideline-supported minutes weekly.

9. Manage diabetes, cholesterol, and weight with coaching and medications as needed.

10. Treat sleep apnea and keep regular sleep, which helps blood pressure and recovery. AHA JournalsAmerican College of CardiologyAAFP

---

When to See a Doctor

• Sudden stroke signs: face droop, arm weakness, speech trouble, sudden severe imbalance, new double vision, or a new eye turning inward—even if they go away. Act fast; treatments are time-limited.

• New or worsening double vision, headaches, or weakness after a recent brainstem stroke.

• Choking or frequent coughing with meals, weight loss, dehydration, or repeated chest infections.

• Mood changes (sadness, anxiety) that affect daily life.

• Any medication side effects such as unusual bleeding, black stools, severe muscle pains, or allergic reactions.

---

Things to Eat and Things to Avoid

Eat more of (food-first):

1. Extra-virgin olive oil; 2) Fatty fish (2–3×/week); 3) Beans and lentils; 4) Leafy greens; 5) Nuts and seeds (small handful/day); 6) Whole grains; 7) Colorful fruit (berries, citrus); 8) Yogurt or fermented foods; 9) Tomatoes and other high-potassium vegetables; 10) Adequate water/unsweetened tea. AAFP

Limit or avoid:

1. Tobacco in any form; 2) Excess salt (aim for <2.5 g sodium/day if advised); 3) Processed meats; 4) Deep-fried foods; 5) Sugary drinks; 6) Heavy alcohol; 7) Large portions of refined carbs; 8) Ultra-processed snacks; 9) “Energy” or stimulant drinks; 10) Grapefruit products if you take interacting medicines (ask your pharmacist). AAFP

---

Frequently Asked Questions

1) Is Raymond Syndrome the same as a “brainstem stroke”?
It is one specific brainstem stroke pattern that points to a small lesion in the ventral mid-pons. Many other named brainstem syndromes exist. Radiopaedia

2) Why is my eye turning inward and why do I see double?
Damage to the 6th nerve pathway weakens the outward-pulling muscle, so the eye drifts inward and causes horizontal double vision. NCBI

3) Will the double vision get better?
Sometimes yes—partial recovery over weeks to months is possible. In the meantime, occlusion or prism can help; botulinum or surgery may be considered if it persists. AAO

4) What’s the difference between “classic” and “common” Raymond Syndrome?
Classic includes 6th nerve palsy + opposite-side body weakness and opposite-side lower-face weakness; common spares the facial pathway. EyeWiki

5) What scans are used?
MRI with diffusion shows acute infarct; vascular imaging (CTA/MRA) looks for basilar/vertebral occlusion.

6) Can thrombectomy help brainstem strokes?
In carefully selected basilar artery occlusions, endovascular therapy plus best medical treatment improves outcomes within certain time windows. European Stroke Organisation

7) Is tenecteplase better than alteplase?
Both are used per protocols; emerging guidelines support 0.25 mg/kg TNK as an alternative in some situations, especially when thrombectomy is planned. Your stroke team chooses based on eligibility and timing. Canadian Stroke Best PracticesAHA Journals

8) What medicines will I go home on?
Most people need an antithrombotic (antiplatelet or anticoagulant, not both long-term), a high-intensity statin, and strict blood-pressure and diabetes control. AHA JournalsAmerican College of Cardiology

9) Are there “immune boosters” or stem-cell drugs that cure this?
No. These are investigational only; consider clinical trials, not unregulated treatment.

10) Will I walk again?
Many people improve with rehab. Early, intensive, task-specific therapy helps the brain re-learn skills.

11) Is this the same as Raymond–Céstan or Foville syndromes?
No—those involve different pontine regions and have different signs. Your neurologist localizes the lesion based on your pattern. Wikipedia

12) How long does recovery take?
Recovery varies; most gains occur in the first 3–6 months, but improvements can continue beyond that with ongoing practice.

13) What about driving?
Wait for medical and visual clearance. Persistent double vision or weakness can make driving unsafe.

14) Could this happen again?
Risk decreases a lot when blood pressure, cholesterol, diabetes, rhythm problems, smoking, and diet/exercise are managed well. AHA Journals

15) Who should be on my care team?
Neurologist/stroke specialist, physiotherapist, occupational and speech/swallow therapists, neuro-ophthalmologist or strabismus surgeon, dietitian, and primary-care physician.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 23, 2025.